International Journal of Gynecological Cancer

Papers
(The H4-Index of International Journal of Gynecological Cancer is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study255
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer151
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy119
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry115
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets90
The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer88
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study76
Three-dimensional image of uterine transposition62
Growing teratoma syndrome61
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review61
Inguinofemoral lymphadenectomy technique in 10 steps60
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization59
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery51
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico47
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer47
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation41
Evaluating the use of machine learning in endometrial cancer: a systematic review40
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation40
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer40
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades39
Laparoscopic approach to paravaginal low-grade sarcoma39
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma39
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies37
Well-differentiated papillary mesothelial tumor of the peritoneum37
Importance of stress management in gynecological cancer36
Management of stage III and IVa uterine cancer36
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy35
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins34
Vulvar cancer resection with V–Y advancement flap reconstruction33
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 202432
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care32
Use of quadratus lumborum block in gynecologic procedures31
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management31
0.055250883102417